Indication

Candida pleural space infection

Candida pleural space infection, commonly known as Candida empyema thoracis or fungal pleuritis, is an invasive fungal condition characterized by pathological colonization and inflammatory infection within the pleural cavity by Candida species, most frequently Candida albicans or Candida glabrata. Read more about Candida pleural space infection

10 drugs 9 manufacturers

Advertisement

Drugs that treat it

Common Candida pleural space infection therapies.

Showing 1–9 of 10 drugs

Filter & compare in the drug finder →Opens the drug finder with Candida pleural space infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Candida pleural space infection.

Candida pleural space infection, commonly known as Candida empyema thoracis or fungal pleuritis, is an invasive fungal condition characterized by pathological colonization and inflammatory infection within the pleural cavity by Candida species, most frequently Candida albicans or Candida glabrata.

It primarily affects the respiratory and thoracic systems, typically occurring in hospitalized, critically ill, or immunocompromised patients following thoracic surgery, esophageal perforation, chest tube instrumentation, or contiguous spread from intra-abdominal infections.

Defining clinical and pathophysiological features include systemic signs of sepsis such as fever and leukocytosis alongside respiratory distress, accompanied by purulent or exudative pleural effusion demonstrating viable yeast on pleural fluid microscopy or culture.

Personalize your experience

Follow Candida pleural space infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it